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A detailed understanding of the mechanisms that
establish or maintain the latent reservoir of HIV will
guide approaches to eliminate persistent infection.
We used a cell line and primary cell models of HIV la-
tency to investigate viral RNA (vRNA) expression and
the role of the host transcriptome using single-cell
approaches. Single-cell vRNA quantitation identified
distinct populations of cells expressing various
levels of vRNA, including completely silent popula-
tions. Strikingly, single-cell RNA-seq of latently
infected primary cells demonstrated that HIV down-
regulation occurred in diverse transcriptomic envi-
ronments but was significantly associated with
expression of a specific set of cellular genes. In
particular, latency was more frequent in cells ex-
pressing a transcriptional signature that included
markers of naive and central memory T cells. These
data reveal that expression of HIV proviruses within
the latent reservoir are influenced by the host cell
transcriptional program. Therapeutic modulation of
these programs may reverse or enforce HIV latency.
INTRODUCTION
Transcriptional downregulation of HIV in latently infected cells
results in persistent HIV infection despite antiretroviral therapy.
The mechanisms that enforce latency are complex and only
partially understood but involve a repressive chromatin state
that is regulated by diverse histone modifications (Turner and
Margolis, 2017). Such latently infected cells appear to persist
in infected patients for decades, their frequency little changed
by years of antiretroviral therapy (ART) (Crooks et al., 2015;
Siliciano et al., 2003). Furthermore, latently infected CD4+
T cells can contribute to the rebound of infection upon cessation
of antiviral therapy and thus are a principal barrier to curing HIV
infection (Chun et al., 2010; Davey et al., 1999; Finzi et al., 1997).
Intensive efforts currently focus on strategies to eliminate HIV-in-
fected reservoir cells, and a major strategy to achieve this
goal involves treatment with pharmacological latency-reversing
agents (LRAs) to upregulate HIV expression in infected cells,Ce
This is an open access article under the CC BY-Nso that these cells can be recognized and cleared by the host im-
mune system (Archin et al., 2012; Søgaard et al., 2015; Zhu et al.,
2012). However, LRAs thus far are ineffective at reactivating HIV
in a majority of latently infected cells (Ho et al., 2013). Multiple
mechanisms of regulation of proviral expression may limit the
response to LRAs acting through a singlemechanism, in addition
to the heterogeneous phenotypic nature of latently infected cells
themselves. Several host factors, such as CDK9 and CyclinT1,
are known to regulate HIV transcription in various models of la-
tency (Tyagi et al., 2010), and epigenetic features play a central
role in antagonizing or augmenting the role of viral transactivation
(He et al., 2002; Turner and Margolis, 2017; Van Lint et al., 2013,
Friedman et al., 2011; Tripathy et al., 2015). It has also been
demonstrated in model systems that establishment of latency
can be driven by stochastic fluctuations in the viral transcription
factor Tat (Razooky et al., 2015; Weinberger et al., 2005). Deter-
mination of how the host cell transcriptome affects viral expres-
sion and latency may identify targets to enhance or reverse
latency.
One limitation of previous studies examining HIV latency was
using cells considered as bulk populations and not as single
cells, missing critical insights. The latently infected CD4+ T cell
reservoir is inherently diverse, with each provirus exhibiting a
potentially unique combination of the effects of integration site,
epigenetic modifications, and infected cell phenotype. For
example, CD4+ T cells, the major host cell for HIV infection,
can exist as several different developmental stages, categorized
as naive (Tn), central (Tcm) and effector memory (Tem), and
effector cells. Each of these subtypes have distinct transcrip-
tional and epigenetic programs that could affect the activity of
the integrated HIV promoter (Durek et al., 2016). Additionally,
biological noise and stochastic fluctuations in transcriptional ac-
tivity could play an important role in either establishment or
reversal of latency (Dar et al., 2014).
Given the multitude of factors that can affect the establish-
ment and maintenance of latent infection, the application of
methods that permit the analysis of single cells will be required
to fully characterize latency and the mechanisms that determine
HIV latency. Recent technological breakthroughs in analysis of
individual cells by single-cell RNA sequencing (scRNA-seq)
now permit detailed characterization of heterogeneous behav-
iors of individual cells (Hashimshony et al., 2016; Macosko
et al., 2015; Picelli et al., 2013; Villani and Shekhar, 2017). These
methods have provided insights into biological systems andll Reports 25, 107–117, October 2, 2018 ª 2018 The Author(s). 107
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revealed surprising diversity in cultures of cells previously
assumed to be uniform (Buettner et al., 2015; Shalek et al.,
2014; Villani and Shekhar, 2017). We hypothesized that within
latently infected populations, there exist subpopulations with
differing patterns of viral and host gene transcription at rest
and after host cell activation. Moreover, we hypothesized that
this transcriptional diversity within latently infected cell popula-
tions is influenced by an identifiable set of genes. To investigate
these hypotheses, we applied two single-cell assays to models
of latent HIV infection. Analysis of vRNA at the single-cell level re-
vealed the existence of diverse levels of vRNA expression both at
rest and after LRA stimulation, and scRNA-seq of latently in-
fected primary cells indicated that HIV downregulation occurs
in diverse environments but was significantly associated with
expression of a specific set of host cell genes. This latency asso-
ciated signature suggests that downregulation of HIV in primary
cells is regulated by the underlying transcriptional program of the
infected cells. These insights illustrate an important role for the
host cell environment in HIV latency and will guide the develop-
ment of therapies that can achieve optimal reactivation of the
latent reservoir.
RESULTS
Heterogeneous Viral RNA Induction by LRAs and a
Threshold for Viral Protein Expression
To measure viral RNA (vRNA) in individual latently infected CD4+
T cells, we used an approach that combined flow sorting of sin-
gle cells into 96-well PCR plates followed by real-time qPCR for
unspliced HIV RNA. To determine the utility of this approach, we
first analyzed vRNA levels in N6 cells, a Jurkat-derived CD4+
T cell line that is latently infected with HIV. This cell line contains
a full-length integrated copy of the NL4-3 strain of HIV, with the
nef open reading frame replaced by coding sequence for themu-
rine Heat-shock antigen (HSA) reporter. Flow cytometry for sur-
face expression of the HSA reporter protein encoded by this viral
clone allowed us to identify HIV reactivation in N6 cells. We stim-
ulated N6 cells with three different LRAs—the histone deacety-
lase inhibitor vorinostat (3 mM), the protein kinase C (PKC)
agonist prostratin (3 mM), and tumor necrosis factor-alpha
(TNFa; 100ng/mL)—and assayed vRNA levels in 144 cells for
each condition at 24 hr (Figure S1A). In unstimulated cells, the
majority of cells had undetectable vRNA levels, but a subpopu-
lation (19%) expressed low levels of vRNA, detectable but typi-
cally below the lower limit of quantification. Upon stimulation,
cells treated with either of the three LRAs exhibited a strong up-
regulation of vRNA and the appearance of detectable HSA pro-
tein expression. A wide range of vRNA levels from 1 to 3,442
copies per cell was detected across the population, with coeffi-
cients of variation ranging from 93% for vorinostat to 164% for
TNFa. vRNA levels did not exceed 3,442 copies per cell, sug-
gesting a uniform restriction of vRNA across the clonal cell line.
Notably, expression of virally encoded HSA became pro-
nounced only when vRNA levels were above 500 copies per
cell, suggesting that a threshold of vRNA is required for transla-
tion of a detectable quantity of HSA in these cells. For all LRAs,
the percentage of vRNA+ cells exceeded the percent of HSA+
cells, indicating that protein-based viral reporters significantly108 Cell Reports 25, 107–117, October 2, 2018underestimate the fraction of responding cells (Figure S1B).
Thus, these data demonstrate that stimulation of latently infected
cells with LRAs induces a broad spectrum of diverse vRNA/anti-
gen responses and that a significant population of vRNA+ cells
can be detected that are not producing detectable viral antigen.
We also examined the response of N6 cells to vorinostat at
different times after stimulation (Figure S2A) and at different con-
centrations (Figure S2B). These data demonstrated significant
variation in the kinetics and thresholds of reactivation for vRNA
expression among individual cells.
Establishment of a Primary CD4+ T Cell Model for HIV
Latency
To further examine the behavior of latently infected cells, we
established a primary CD4+ T cell model of HIV latency. This
model is similar to models from other laboratories (Kim et al.,
2014; Mohammadi et al., 2014; Sahu et al., 2006; Tyagi et al.,
2010) and involves infecting activated CD4+ T cells with a
GFP-expressing HIV strain (Yang et al., 2009) and sorting to
obtain a pure infected population, followed by long-term
(8–12 weeks) co-culture with H80 cells (Figure 1A). During this
period of culture, we observed highly variegated transcriptional
downregulation of HIV gene expression within the infected pop-
ulation. Some cells exhibited downregulation of GFP expression
to undetectable levels (GFP), while others maintained interme-
diate or high levels of expression (Figures 1B and 1C). To test the
ability of the latently infected cells to reactivate viral gene expres-
sion in response to T cell receptor (TCR) engagement, we puri-
fied GFP cells from the infected cell culture and stimulated
them with anti-CD3/CD28 beads. These cells re-expressed
GFP to nearly 90% by 3 days, indicating that they were indeed
latently infected and that initial loss of GFP expression was not
due to deletion of the provirus or outgrowth of a contaminating
uninfected population (Figure 1D).
Single-Cell Analysis of vRNA in Latently Infected
Primary CD4+ T Cells
To investigate the diversity of vRNA expression in latently
infected primary cells, we analyzed sorted single cells from the
infected population at 12 weeks post-infection (wpi) without
stimulation (Figure 2). For comparison, we also examined pro-
ductively infected cells at 2 days post-infection (dpi). Using linear
regression, we found that vRNA levels in primary CD4+ T cells
were linearly correlated with GFP protein expression for
both time points (R2 = 0.179, p = 1.71 3 107 for 12 wpi;
R2 = 0.475, p = 1.35 3 1021 for 2 dpi). This contrasts with the
apparent threshold of vRNA required for viral protein expression
in N6 Jurkat cells (Figure S1). The 2 dpi population expressed
significantly higher overall levels of vRNA than cells at 12 wpi
(p < 0.00001, Mann-Whitney test), indicating that transcriptional
downregulation accounted for part of the reduction in GFP pro-
tein expression over time, but interestingly, a subset of 12 wpi
cells expressed vRNA to a similar level to that seen at 2 dpi. At
12 wpi, 12% of cells exhibited undetectable vRNA, indicating
transcriptional latency. Overall, this analysis shows that after
long periods in culture, most infected cells downregulate viral
gene expression at both the RNA and protein level, but the extent
of this downregulation varied greatly between individual cells
Figure 2. Single-Cell Viral RNA and Antigen Expression in the Pri-
mary Cell Latency Model Is Heterogeneous
Single infected primary CD4+ T cells at 2 dpi (blue) and 12 wpi (red) were flow
sorted and analyzed for vRNA expression by single-cell qPCR (sc-qPCR). GFP
mean fluorescence intensity (MFI) for each cell was plotted against vRNA
copies per cell. Each dot represents data from an individual cell.
Figure 1. Primary CD4+ T Cell Model of HIV Latency
(A) Graphical depiction of primary cell model of latency. Activated cells were
infected with pNL4-3-D6-dreGFP, a GFP-expressing HIV clone, and infected
(GFP+) cells were isolated by flow sorting.
(B) After 8 weeks of co-culturing the sorted GFP+ population with H80 cells,
cells displayed heterogeneous levels of virally encoded GFP expression, with
40% now being GFP.
(C) The percentage GFP cells over time was determined by flow cytometry.
Data shown are a representative sample from one of three separate donors.
(D) Latently infected cells were isolated by flow sorting of the lowest 15%GFP-
expressing cells from the infected cell culture. These cells were then stimu-
lated with anti-CD3/CD28 beads for 3 days. GFP expression wasmeasured by
flow cytometry before (GFP) and after (GFP + aCD3/CD28) stimulation and
compared with uninfected (uninf) cells. Error bars represent SDs of two
technical replicates.and that an HIV-infected culture contains cells with diverse tran-
scription levels.
Differential Proviral Transcription in Cells with Different
Host Cell Gene Expression Patterns
We next sought to determine the relationship between host cell
gene expression patterns and expression of vRNA by performing
single-cell RNA-seq (scRNA-seq). We first compared the single-
cell transcriptomes of 5,666 uninfected and 3,565 infected CD4+
T cell populations from two donors. Reduction of the dimension-
ality of the transcriptomes of single cells to two dimensions by
t-distributed stochastic neighbor embedding (tSNE) created a
single-cell map of the clusters of cells. Overall, the infected cells
clustered near the uninfected cells, indicating overall similar tran-
scriptome profiles (Figure 3A). However, the cells from the twodonors clustered distinctly, indicating differences in transcrip-
tomic profiles between donors (Figure 3A). The inter-donor dif-
ferences could represent true biological differences but may
also incorporate some batch specific phenomena, as the donors
were cultured and processed for scRNA-seq at different times.
As such, we focused our attention on analyzing differences be-
tween infected and uninfected cells and between infected cells
within the donors. Unsupervised graph-based clustering identi-
fied seven clusters on the basis of gene expression (Figure 3B).
For themost part, these clusters represent a continuous gradient
of T cell gene expression rather than discrete clusters of cell sub-
sets. This result is consistent with previous scRNA-seq analysis
of human T cells (Villani and Shekhar, 2017). Nevertheless, the
clusters exhibited significant differences in gene expression.
For example, clusters 0, 5, and 3 had higher levels of expression
for TNFSF10 and ID2, while clusters 4, 1, and 2 had higher
expression ofCCR7 and SELL (Figure 3C). Cluster 6 had upregu-
lation of genes that indicated feeder cell contamination and were
excluded from further analysis. Among 21,258 total genes de-
tected in all samples, we identified 12 upregulated and 6 down-
regulated transcripts (p % 0.001, likelihood-ratio test) when
comparing infected and uninfected cells (Figure 3D; Table S1).
As a marker of viral expression, GFP was the most differentially
expressed transcript, followed by IFITM1 and MIF (Figure 3D;
Table S1). IFITM1 has been shown to be upregulated upon HIV
infection and even identified as a candidate marker of latently in-
fected cells (Raposo et al., 2017), andMIF has been shown to be
elevated in plasma from HIV-infected individuals and may play a
role in viral replication (Regis et al., 2010). These results sug-
gested that after 12 weeks of culture, infected and uninfected
CD4+ T cells have overall similar transcriptomes, but there are
a small number of transcripts that are differentially expressed
as a result of infection.
Next, we focused our analysis on differences within the in-
fected cell population. We included the scRNA-seq from an
additional 641 cells from a third donor, interrogating in total theCell Reports 25, 107–117, October 2, 2018 109
Figure 3. Single-Cell Transcriptome Analysis of Infected and Uninfected CD4+ T Cells
(A) Two-dimensional plot from unsupervised clustering by t-distributed stochastic neighbor embedding (tSNE) of the single-cell transcriptomes of 5,666 unin-
fected (blue) and 3,565 infected (red) CD4+ T cell populations from two donors. Individual dots represent single cells. Uninfected cells were cultured in parallel with
the infected cells under identical conditions.
(B) Two-dimensional tSNE plot with identified distinct clusters determined by graph-based clustering.
(C) Heatmap of the top five transcripts differentially expressed between each cluster (likelihood ratio test; p % 0.05). Each pixel column is the expression of an
individual cell. Transcripts are on the rowswith the normalized expression (Z scores) colored by the legend (yellow,more upregulated; blue, more downregulated).
(D) Heatmap of transcripts differentially expressed between infected and uninfected cells (likelihood ratio test; p% 0.05). Each pixel column is the expression of
an individual cell. Transcripts are on the rows with the normalized expression (Z scores) colored by the legend (yellow, more upregulated; blue, more down-
regulated).transcriptomes of 4,206 infected cells from three donors. Again,
the three donors clustered distinctly, indicating differences in
overall transcriptomes among the donors (Figure 4A). We identi-
fied 2,435 cells with detectableGFP transcript expression repre-
senting 68.5%, 28.9%, and 48.4% of the infected cells in the
three donors, respectively (Figure 4C). The cells with no detect-
able GFP expression are candidate latently infected cells.
Consistent with our previous observation, viral gene expression,
as measured by GFP RNA levels, was heterogeneous within the
infected cell population. Importantly, cells with undetectable
viral transcription were observable in all the clusters, indicating
that latency can be established in diverse cellular environments.
However, significant differences in viral gene expression were110 Cell Reports 25, 107–117, October 2, 2018found between some clusters (Figure S3). Specifically, cells
from two of the three donors (donors 1 and 3) contained clusters
that were significantly enriched for high levels of GFP expres-
sion, as well as clusters that were enriched for GFP cells (Fig-
ures 4B and S3). The other donor (donor 2) also exhibited
apparent differences in viral gene expression between clusters,
but these differences were not statistically significant, possibly
because of the smaller number of cells recovered for this donor.
To investigate this observation further, we then determined the
differences in gene expression between cells actively tran-
scribing vRNA (GFP+) and cells with no vRNA expression
(GFP). We found 33 upregulated and 13 downregulated tran-
scripts in GFP+ cells compared with GFP cells (p % 0.001,
Figure 4. Differential Gene Expression in In-
fected Cells with Different Levels of Viral
Transcription
(A) Two-dimensional plot from unsupervised
clustering by t-distributed stochastic neighbor
embedding (tSNE) of the single-cell tran-
scriptomes of 4,206 infected CD4+ T cell pop-
ulations from three donors. Individual dots repre-
sent single cells. Cells were taken from infected
cultures at 12 wpi and consist of a mixture of GFP+
and GFP cells.
(B) Normalized transcript expression level of GFP
on the tSNE plot representation. Legend indicates
normalized transcript values.
(C) Violin plots detailing the expression levels of
GFP in each of the three donors infected cells.
(D and E) Volcano plots of genes significantly
differentially expressed genes in GFP+ cells (D) or
high-GFP+ cells (R2 GFP expression) (E) with
adjusted log p value and log2 fold change
graphed. Only significant genes are shown. Up-
regulated transcripts in red and downregulated in
blue.
(F) Ingenuity Pathway Analysis (IPA; QIAGEN) of
predicted functional annotations (diseases and
functions) for gene lists comparing all GFP+ or the
high-GFP+ and GFP cells.
(G) Predicted activation or inhibition of canonical
pathways. Z score indicates activation versus in-
hibition of indicated functions.likelihood-ratio test; Figure 4D; Table S2). We also determined
the differences in expression in cells with high vRNA expression
(GFPhi; top 10 percentile GFP expression; normalized expres-
sion R 2) compared with GFP cells and found 87 upregulated
and 42 downregulated transcripts (p % 0.001, likelihood-ratio
test; Figure 4E; Table S3). Genes with higher expression in the
GFPhi subset included IL2RA (CD25), TNFRSF4 (OX40L), and
TNFRSF18 (GITR), consistent with previous observations that
activated T cells permit higher levels of HIV transcription (Wil-
liams and Greene, 2007). In contrast, cells with undetectable
HIV gene expression exhibited higher expression of CCR7,
CXCR4, SELL (CD62L), and the cytokine receptor CD127. Visu-
alization of the expression patterns for a number of these genes
in individual donors also suggested an enrichment of latently in-
fected cells in clusters with higher CCR7, CD27, and SELL
expression and a greater frequency of cells with higher viral tran-
scription in clusters with expression of IL2RA, HLA-DRA, and
CD38 (Figure 5). Thus, although HIV transcriptional downregula-
tion can occur in cells with diverse phenotypes, it occurs with aCellhigher frequency in cells that express a
specific set of cellular genes.
To investigate the temporal dynamics
of the observed gene changes, we per-
formed scRNA-seq on 7,300 infected
cells from an additional donor after
6 weeks of culture and identified 2,599
GFP+-expressing cells (Figure S4A). As
in our analysis of cells at 12 wpi, we
observed HIV downregulation in all tran-scriptomic clusters but also found that some clusters were
significantly enriched for high HIV gene expression or for down-
regulation (Figure S4B). We found seven or nine upregulated and
three or two downregulated genes when comparing the GFP+
(p % 0.001, likelihood-ratio test; Table S4) or high GFP+ (top
10 percentile of GFP expression; Table S5) with GFP cells,
respectively (Figure S4C). Interestingly, even after only 6 weeks
of culture, we found that cells with undetectable vRNA expres-
sion as measured by GFP expression had higher expression of
several of the same genes we observed at 12 wpi, including
TCF7 and CD27 (Figures S4C and S4D).
HIV Transcription Is Preferentially Downregulated in
Cells with Greater Proliferative Potential
To investigate whether the set of genes that differentiate tran-
scriptionally silent HIV infection (GFP) from transcriptionally
active infection (GFP+) represented differential activity of specific
biological pathways, we performed Ingenuity Pathway Analysis
(Jiménez-Marı́n et al., 2009) and identified significant enrichmentReports 25, 107–117, October 2, 2018 111
Figure 5. Expression Patterns of Host Cell
Genes that AssociatewithHIV Transcription
Level
(A and B) Normalized expression pattern for
selected genes whose expression negatively (A) or
positively (B) associated with viral gene expres-
sion (GFP) plotted on the tSNE plot representation.
Each dot represents and individual cell. Legends
indicate normalized transcript values. Data are
derived from one of three donors.of genes involved in cell death and survival and cellular prolifer-
ation when comparing all GFP+ or GFPhi cells to GFP cells (Fig-
ure 4F). We then determined the predicted activation status of
the genes in the cell death and survival and cellular growth and
proliferation categories in the high-GFP+ cells and found that
transcripts were changed in a way that predicted inhibition of
cell death and proliferation compared with GFP cells (Fig-
ure 4G). A recent study also found activation of cellular survival
and OX40 pathways during HIV infection (Kuo et al., 2018). On112 Cell Reports 25, 107–117, October 2, 2018the basis of this analysis, we hypothe-
sized that HIV transcriptional downregu-
lation might be correlated with differential
proliferative potential of the infected cells.
To test this hypothesis, we sorted in-
fected cells at 8 wpi into two populations
on the basis of GFP expression level
(GFP, GFP+) (Figure 6, top). We then
stimulated each population with anti-
CD3/CD28 beads in the presence of
IL-2 100 U/mL for 3 days, then allowed
the culture to expand further in the
absence of stimulation. After 14 days of
expansion, we measured expansion by
counting viable cells. Notably, GFP cells
exhibited the greater fold expansion of
the two cultures (Figure 6, bottom). These
data are consistent with a model in which
HIV transcriptional downregulation oc-
curs preferentially in a specific subset of
cells with greater proliferative potential
and suggest that HIV transcriptional
downregulation in primary CD4+ T cells
is associated with intrinsic biological
properties of host cells.
Viral Downregulation Is Associated
with T Cell Subset Identity
The observation that several transcripts
that define specific T cell subsets
(CCR7, SELL, CD27) are differentially ex-
pressed within infected cells with the
lowest level of HIV gene expression sug-
gested a relationship between specific
CD4+ T cell subsets and transcriptional
downregulation of the HIV promoter.
CD4+ T cells emerge from the thymus asnaive T cells (Tn), then, through a combination of antigenic simu-
lation and cytokine cues, develop linearly into central memory
T cells (Tcm), transitional memory T cells (Ttm), and finally
effector memory T cells (Tem). These subsets are defined by dif-
ferential expression of a set of surface markers including
CD45RO and CCR7. We examined expression of CCR7 and
CD45RO on the surface of infected cells by flow cytometry after
8weeks of co-culture with H80 cells. This staining confirmed that
the infected cell population consisted of a mixture of cells with
Figure 6. HIV Is Preferentially Downregu-
lated in Cells with Higher Proliferative
Capacity
An infected culture of primary CD4+ T cells at 8 wpi
was sorted into two populations on the basis of the
level of GFP expression: GFP and GFP+ (top
right). Equivalent numbers of sorted cells were
then stimulated with aCD3/aCD28 beads for
3 days and then expanded in 100 U/mL IL-2 for
2 weeks. At the end of this period, the fold
expansion for each culture was calculated by
counting live cells using a hemocytometer and
trypan blue exclusion (bottom). Data shown are
from three independent donors. Error bars indi-
cate SDs of two technical replicates. *p < 0.05
(Student’s t test).‘‘naive’’ (CCR7+ CD45RO) phenotype, cells with a Tcm pheno-
type (CCR7+ CD45RO+), and cells with a Tem/Ttm (CCR7
CD45RO+) phenotype (Figure 7, left). Notably, the distribution
of cells within these populations differs from other reports using
a similar model (Tyagi et al., 2010; Yang et al., 2009). This differ-
ence is likely explained by methodological differences in the
preparation of the cells: in one of the previous studies (Tyagi
et al., 2010), the infected cells were reactivated and expanded
post-sorting, while in our experiments, the infected cells were
not re-stimulated after the initial activation. To determine the
level of viral gene expression in each subset, we examined the
percentage of GFP (latent) cells in each subset (Figure 7, right).
All three populations exhibited amixture of GFP andGFP+ cells,
but, consistent with the scRNA-seq, we observed that there was
a gradient of HIV downregulation across the populations, with
CD45RO CCR7+ cells having the highest percentage of GFP
cells and CD45RO+ CCR7 cells exhibiting the lowest. These re-
sults demonstrated that in this latency model, HIV transcription
was preferentially downregulated in cells at the Tn/Tcm end of
the developmental spectrum. Nevertheless, we also observe
heterogeneous viral expression levels within each subset,
consistent with the hypothesis that latency is the output of a
convergence of factors at the level of each individual cell. In
this model, we would expect a diverse population of latently in-
fected cells, the most frequent phenotype of which would reflect
themost common convergence of these influences: (1) a cell that
had recently returned to the central memory pool from a highly
activated effector population prone to the initial stages of HIV
infection and (2) a provirus whose expression had become
restricted by epigenetic marks.CellDISCUSSION
In this study we used single-cell ap-
proaches to determine the expression of
viral and host cell genes in individual
latently infected cells. Our approach pro-
vides a view of the latently infected
cellular subsets, revealing that (1) latency
occurs in diverse cellular environments,
(2) transcriptional downregulation is
significantly associated with a distincthost cell transcriptional signature, and (3) transcriptional down-
regulation occurs preferentially in cells that possess greater pro-
liferation potential than cells in which viral transcription remains
high.
Over the past few years, single-cell methods have become
widely used and have provided powerful new insights into het-
erogeneity in biological systems that were previously assumed
to be homogeneous (Linnarsson and Teichmann, 2016; Shalek
et al., 2014; Villani and Shekhar, 2017). These methods are
particularly useful to the study of virus-host interactions, in which
multiple layers of complexity arise from variation in both host
cells and infecting viruses (Ciuffi et al., 2016). The HIV latent
reservoir, for example, consists of thousands of genetically
distinct viral genomes, including those encoding immune escape
variants, that persist as transcriptionally silent proviruses inte-
grated into a range of genomic locations. Furthermore, expres-
sion of these proviruses is regulated by a wide range of dynamic
chromatin modifications and host cell transcription factors that
can be divergently expressed and differentially active in different
CD4+ T cell subpopulations. The latent HIV reservoir thus repre-
sents not a single, uniform target but a diverse mixture of several
subpopulations of infected cells, potentially with fundamentally
different characteristics. The development of strategies to reac-
tivate or eliminate these cells may need to account for this
diversity within the latent reservoir. For example, targeting this
reservoir with LRAs may require separate strategies for different
subtypes of cells rather than a ‘‘one size fits all’’ approach.
Consistent with this notion, upon a single round of induction, in-
dividual LRAs typically disrupt latency in only a fraction of repli-
cation competent proviruses (Ho et al., 2013). As such there is anReports 25, 107–117, October 2, 2018 113
Figure 7. HIV Is Preferentially Downregu-
lated in Cells Expressing Tn and Tcm
Markers
Infected cells at 8 wpi were stained for surface
markers CD4, CD45RO, and CCR7 to identify
different CD4+ T cell subsets. CD45RO CCR7+
cells represent naive T cells (Tn), CD45RO+CCR7+
cells represent central memory cells (Tcm), and
CD45RO+ CCR7 cells represent a mix of transi-
tional memory T cells (Ttm) and effector memory
T cells (Tem). The fraction of GFP cells in each
gate was then calculated and plotted (right). Data
shown on the right represent the average of four
independent donors. Error bars indicate SDs of
biological replicates. *p < 0.05 (Student’s t test).urgent need to study latency in the context of approaches that
can observe and characterize individual latently infected cells.
Prior studies have also applied single-cell approaches to the
study of HIV latency, although with significantly different meth-
odologies. Wiegand et al. (2017) used cell-associated HIV
RNA/DNA quantitation combined with single HIV genome
sequencing, both at limiting dilution, to detect diversity of viral
transcription from individual proviruses within samples from pa-
tients on antiretroviral therapy. Similar to our results, they found
that a minor subset of latently infected cells express detectable
RNA in the absence of stimulation and that vRNA levels differ
greatly from infected cell to infected cell. Likewise, Bui et al.
(2015) found that the burst size of virus release from single in-
fected cells varies over a wide range. Flow cytometry using
probes for viral transcripts has also yielded insights into diversity
of virus and host gene expression in individual cells during infec-
tion (Baxter et al., 2016.; Bolton et al., 2017; Martrus et al., 2016).
Two recent publications have also examined HIV latency using
scRNA-seq of a primary cell model (Golumbeanu et al., 2018)
and from sorted patient samples (Cohn et al., 2018), yielding
important insights. In particular, Golumbeanu et al. (2018)
observed two clusters of cells in a primary cell model system
that exhibited distinct transcriptional phenotypes, associated
with different levels of viral gene expression. Furthermore, these
investigators identified a transcriptional signature that distin-
guished these clusters. This signature contains some of the
same genes we observe as being associated with HIV gene ex-
pressing in our study, such as IL-32, GAPDH, HLA-E, and CD96,
but also many different genes (Golumbeanu et al., 2018).
Using a single-cell vRNA assay, we found that viral transcrip-
tion levels are variable among individual latently infected cells.
This observation was true for both a Jurkat-derived cell line
(N6) and latently infected primary cells. In both model systems,
a sizable subpopulation of latently infected cells transcribed
low levels of vRNA in the absence of stimulation. Furthermore,
the data demonstrate that antigen-based assays for latency
reversal significantly underestimate the fraction of responding
cells after stimulation with LRAs. N6 cells exhibited an apparent
threshold of vRNA expression before virally encoded antigen
became detectable, while for primary cells, this relationship
was more complex. The reason for this difference is unclear114 Cell Reports 25, 107–117, October 2, 2018but could be related to the greater levels of underlying heteroge-
neity in primary cells.
In our primary cell latency model, we observed only minor dif-
ferences between infected and uninfected cells using scRNA-
seq, suggesting that viral reprogramming of infected cells during
latency is limited. This finding is consistent with a previous pop-
ulation analysis of the transcriptome of infected cells using a
similar model (Mohammadi et al., 2014). However, the virus
used in these studies lacks expression of most viral proteins in
order to limit cytopathic effect and thus may not reflect the full
impact of an intact replication competent virus on the host cell.
In contrast, we observed a significant association between activ-
ity of the HIV promoter and the host cell transcriptome within the
infected cell population. Thus, our data argue that viral transcrip-
tion during latency is influenced by the underlying environment of
the infected host cells. In particular, we observed a clear prefer-
ence for HIV downregulation in cells expressing markers of Tn
and Tcm subsets, while effector and activated cells were asso-
ciated with higher levels of viral gene expression. These results
thus suggest a role for T cell subset identity and intracellular envi-
ronment in regulating the outcome of infection. Consistent with
this notion, it has recently been demonstrated that HIV preferen-
tially enters latency if infection occurs during a period of global
cellular transcriptional downregulation as cells return to rest
from activation (Shan et al., 2017). It is unlikely that the preferen-
tial downregulation we observe in Tn and Tcm in our primary cell
model is related to differential mutagenesis of the provirus,
because almost 90% of sorted latent (GFP) primary cells in
our model re-expressed GFP upon TCR stimulation. Our finding
of preferential HIV downregulation in Tn and Tcm cells is also
consistent with outgrowth studies from suppressed patents
(Soriano-Sarabia et al., 2014).
Several other studies have also noted significant differences
between T cells subsets with respect to the establishment, main-
tenance, or reversal of latency, confirming that this is an area that
will require further investigation. Tsunetsugu-Yokota et al. (2016)
reported using an ex vivo infectionmodel that latent proviruses in
cells with a naive phenotype are difficult to reactivate compared
with proviruses within thememory cell compartment, suggesting
a distinct mechanism of latency in these cells. Consistent with
our findings, Grau-Expósito et al. (2017) used a single-cell
flow-fluorescence in situ hybridization (FISH) assay of patient
derived samples to identify effector memory T cells as the subset
with the highest level of proviral transcription. Another recent
study used flow cytometry to characterize cells expressing
vRNA and Gag protein in both viremic and antiretroviral ther-
apy-treated cells and found that proviruses in Tcm and Tem cells
exhibited distinct patterns of reactivation with LRAs (Baxter
et al., 2016).
Our finding that HIV is preferentially downregulated in cells
with greater proliferation potential is also consistent with this hy-
pothesis, and this phenomenonmay contribute to persistence of
the reservoir. It was also recently reported that HIV-infected cells
exhibit long-term cell survival through expression of BIRC5 (Kuo
et al., 2018). We did not observe upregulation of BIRC5 in our
model system, although we did observe a related protein,
BIRC3, being upregulated in cells with active HIV transcription.
It is not yet clear whether viral gene expression contributes to
increased infected cell survival in our system or whether,
conversely, the viral infection trajectory is guided by pre-existing
cellular phenotypic diversity.
The molecular basis for differential viral downregulation across
CD4+ T cell subtypes is unclear. As T cells develop along a linear
developmental trajectory from Tn to Tcm, and then to Ttm and
Temcells, they undergo progressive epigenetic remodeling, char-
acterized by de-repression of cellular genes and loss of histone
methylation islands that regulateexpressionof thesegenes (Durek
et al., 2016). Thus, the pattern of HIV downregulation we observe
mirrors the overall epigenetic programof these cells, suggesting a
link between the two. In addition to epigenetic differences, the ac-
tivity of other important mechanisms of HIV transcriptional regula-
tion, such as Tat or transcriptional elongation factors (Kim et al.,
2011; Razooky et al., 2015; Weinberger et al., 2005; Yukl et al.,
2018), may differ in distinct T cell subsets. Nevertheless, with
each subset, we see amixture of GFP+ andGFP cells, indicating
that subset identitymay result in a given provirus being vulnerable
to viral downregulation, but other factors, such as integration site
or stochasticity, must also contribute to the process of entry into
latency (Chen et al., 2017; Weinberger et al., 2005).
Overall these findings indicate that the latent reservoir is a
complex and diverse population of cells but that expression of
specific host cell genes likely plays a role in the preferential
downregulation of the HIV provirus in some T cell subtypes.
The functional roles of the individual genes whose expression
is enriched in the different transcriptional clusters in HIV gene
expression should be investigated. Further studies to under-
stand the mechanisms of latency may lead to more effective
therapeutic approaches to clear persistent proviral infection.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
N6 Jurkat cell model
N6 cells were a generous gift from David Irlbeck (Glaxo SmithKline, Chapel Hill, NC). This cell line was derived from the human Jurkat
T cell line and was made using HIV-1 engineered to express a luciferase reporter in place of the HIV-1 nef gene with an additional
mouse heat stable antigen CD24 (HSA) reporter located just downstream of the luciferase open reading frame, separated by a
T2A element (NLCH-Luci-HSA). NLCH, the parent molecular infectious clone was kindly provided by the laboratory of Dr. Ron
Swanstrom (UNC-Chapel Hill, Chapel Hill, NC) and is a modification of HIV-1 NL4-3 (GenBank U26942) where flanking sequences
were removed. To generate latently infected clones, NLCH-Luci-HSA infected Jurkat cells expressing low levels of HSA were
selected, limit diluted, and individual clones, including clone N6, were expanded in culture. This cell line wasmaintained in RPMI me-
dia with 10% Fetal calf serum (FCS) and penicillin/streptomycin. 500nM Efavirenz was added to the media to prevent spontaneous
virus outgrowth.
Primary cell model of HIV latency
For generation of infected primary model cells, human blood was purchased from Gulf Coast Regional Blood Center (Houston, TX).
Total CD4 T cells were then isolated from human peripheral blood mononuclear cells (PBMCs) by negative selection using Easysep
total CD4 T cell isolation kit (Stem Cell, Vancouver, BC). Purity was determined by staining with anti-CD4-FITC and flow cytometry
and was typically 98%–99%. For infection, 20 million CD4 T cells were activated by mixing with anti-CD3/CD28 beads (Thermo
Fisher) at one bead per cell for 2 days with 100U/mL IL-2. At 2d, the beads were magnetically removed, and the cells infected
with pNL43-D6-dreGFP virus by centrifugation at 600 g for 2h at room temperature, in the presence of 4ug/mL polybrene. At
2dpi, cells were resuspended in staining buffer, and infected (GFP+) cells were isolated using a FACSAria flow sorter (Becton
Dickson). The recovered GFP+ cells were then co-cultured with the human H80 cell line in RPMI media (provided by Darrell Bigner,
Duke University) and 20 U/mL IL-2 for up to 12 weeks. Media for the co-culture was replaced every 2-3 days. Infected cells were
moved to flasks with fresh H80 cells every two weeks. All donors were anonymous. This study was reviewed by the UNC-Chapel
Hill institutional review board (IRB) and was deemed to not constitute human research.
METHOD DETAILS
Generation of HIV stocks
HIV stocks were produced by transient transfection of the human 293T cell line with pNL43-D6-dreGFP plasmid, as well as the pack-
aging plasmids PAX2 and gp160 envelope, using Mirus LT1 tranfection reagent (Mirus Bio, Madison, WI). pNL43-D6-dreGFP was
kindly provided by Robert Siliciano (Johns Hopkins). This virus contains premature stop codons in all viral genes except tat and
rev, and contains a destabilized eGFP gene in the envelope open reading frame (Yang et al., 2009). The gp160 expression plasmid
was derived from the CXCR4-tropic NL4-3 strain and was kindly provided by Ronald Swanstrom (UNC Chapel Hill). Tissue culture
media was replaced at 24 h. At 48 h. supernatant was harvested and spun at 2000 rpm for 5mins to remove cell debris before filtering
through a 0.45mM filter (Millipore, Burlington MA). Aliquots of virus were frozen at 80C.
Single cell vRNA (sc-vRNA) assay
Cells were stained at 1:1000 in phosphate buffered saline (PBS) with the live/dead dye Zombie Violet (ZV; Biolegend, San Diego CA) for
20 mins. Cells were then washed and resuspended in staining buffer (PBS with 2% fetal calf serum and 1mM EDTA). Next, single cells
were sorted into 96-well PCRplateswith 10ml of TCLbuffer (QIAGEN,Hilden, Germany) containing 1%Beta-mercaptoethanol using an
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(SSC) gating, and dead cells were excluded by gating on ZV- cells. Index sorting was used to record fluorophore/GFP intensity for each
cell. After sorting plates were briefly spun and frozen at80C. To extract RNA, plates were thawed and 22 ml of RNA-Clean XP beads
(Beckman Coulter, Brea, CA) added and incubated for 10 mins. Beads were then isolated and washed in 80% ethanol, then
eluted into 10 mL of 1x PCR master mix using Fastvirus (Thermo, Waltham, MA) and primer sets for HIV Gag (GAG-F: ATCAAGCAGC
CATGCAAATGTT, GAG-R: CTGAAGGGTACTAGTAGTTCCTGCTATGTC, GAG-Probe: FAM/ZEN-ACCATCAATGAGGAAGCTGCA
GAATGGGA-IBFQ) and Beta-actin (BAC-F: TCACCCACACTGTGCCCATCTACGA, BAC-R: CAGCGGAACCGCTCATTGCCAATGG,
BAC-Probe: HEX-ATGCCCTCCCCCATGCCATCCTGCGT-IBFQ). This plate was then run on a QS3 (Applied Biosystems, Foster
City, CA) real time thermocycler with a 5 minute reverse transcription step at 50C, followed by 40 cycles of 94C (3 s.), 60C (30 s.).
RNA copy number was determined by comparison to a standard curve of synthesized Gag gblock purchased from Integrated DNA
Technologies (Coralville IA). Wells that failed to amplify Beta actin were excluded from analysis. The lower limit of quantification
(LLOQ) for this assay was seven copies of Gag RNA. Coefficient of variation for technical replicates in the standard curve ranged
from 10%–15% for 5000 copies to 40%–45% for 7 copies. Analysis of uninfected cells indicated a false positive amplification rate of
approximately 1%, with the majority of false positive signals falling below the LLOQ. Sensitivity and precision of this assay was also
benchmarked by analysis of vRNA standards (purchased fromBio-synthesis, Lewisville TX) that were spiked into assay wells with lysis
buffer (Figure S5).
scRNA-seq
scRNA-seq was performed as described (Zheng et al., 2017). Briefly, cellular suspensions were loaded on a GemCode Single-Cell
instrument (10XGenomics, Pleasanton, CA) to generate single-cell beads in emulsion. scRNA-seq libraries were then prepared using
GemCode Single Cell 30 Gel bead and library kit (10X Genomics). Single-cell barcoded cDNA libraries were quantified by quantitative
PCR (Kappa Biosystems, Wilmington, MA) and sequenced on an Illumina NextSeq 500 (San Diego CA). Read lengths were 26 bp for
read 1, 8 bp i7 index, and 98 bp read 2. Cells were sequenced to greater than 50,000 reads per cell. The Cell Ranger Single Cell Soft-
ware Suite was used to perform sample de-multiplexing, barcode processing and single-cell 30 gene counting (Zheng et al., 2017).
Reads were aligned to human genome release Hg38 with GFP nucleotide sequence added as an additional gene. Graph based cell
clustering, dimensionality reduction and data visualization were analyzed by the Seurat R package (Satija et al., 2015). Cells that ex-
hibited high transcript counts indicative of cells with abnormal expression or multiple cells within single droplet (> 7500 total tran-
scripts), > 0.1% mitochondrial transcripts (cellular stress), or transcripts characterized by the H80 feeder cells were excluded
from analysis. scRNA-seq data shown in the main text are from three donors at 12 wpi. An additional donor was analyzed at
6 wpi and these data are shown in the supplemental information.
Antibodies/flow cytometry
For flow cytometry, cells were stained in 100 ml staining buffer (PBS with 2% FCS and 1 mM EDTA). Staining was carried out for
30 mins. on ice, before washing with PBS and resuspension in staining buffer. Flow cytometry was carried out on a BD Fortessa
(Becton Dickson). Antibodies/fluorophores used for staining were anti-CD24-PE, anti-CD4-BV605, anti-CD45RO-BV785, anti-
CCR7-APC. All antibodies were purchased from Biolegend.
QUANTIFICATION AND STATISTICAL ANALYSIS
Differentially expressed transcripts were determined in the Seurat R package utilizing the Likelihood-ratio test for single cell gene
expression statistical test (McDavid et al., 2013) and resulting p values were adjusted for multiple comparisons using Bonferroni
correction within Seurat. Significantly changed genes were identified as an adjusted p value% 0.05. Enriched gene pathway analysis
and predicted pathway activation were determined using Ingenuity Pathway Analysis (QIAGEN) software. For Figure 2, R2 values
were calculated by linear regression, with p values determined for a null hypothesis of the slope being zero. For data in Figures 6
and 7, analysis was performed with two tailed Students t test, with significance indicated by p > 0.05.
DATA AND SOFTWARE AVAILABILITY
scRNaseq data has been deposited in the Biosample database. Accession numbers are: SAMN08685499, SAMN08685500,
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